| Primary |
| Crohn's Disease |
51.6% |
| Viral Hepatitis Carrier |
8.4% |
| Colitis Ulcerative |
5.3% |
| Colitis Microscopic |
3.2% |
| Malignant Melanoma |
3.2% |
| Anxiety |
2.1% |
| Aspergillosis |
2.1% |
| Chronic Graft Versus Host Disease In Skin |
2.1% |
| Constipation |
2.1% |
| Foreign Body In Eye |
2.1% |
| Fungal Infection |
2.1% |
| Gastrointestinal Disorder |
2.1% |
| Hot Flush |
2.1% |
| Hypertension |
2.1% |
| Intestinal Villi Atrophy |
2.1% |
| Lung Infection |
2.1% |
| Seasonal Allergy |
2.1% |
| Anaemia |
1.1% |
| Antacid Therapy |
1.1% |
| Antiviral Prophylaxis |
1.1% |
|
| Pancreatitis Acute |
12.5% |
| Fungal Infection |
8.3% |
| Vomiting |
8.3% |
| Abdominal Distension |
4.2% |
| Anxiety |
4.2% |
| Circulatory Collapse |
4.2% |
| Cytolytic Hepatitis |
4.2% |
| Diabetes Mellitus |
4.2% |
| Febrile Convulsion |
4.2% |
| Gastrointestinal Pain |
4.2% |
| Generalised Oedema |
4.2% |
| Haemoglobin Decreased |
4.2% |
| Hair Texture Abnormal |
4.2% |
| Intestinal Obstruction |
4.2% |
| Liver Abscess |
4.2% |
| Myalgia |
4.2% |
| Off Label Use |
4.2% |
| Osteonecrosis |
4.2% |
| Osteoporosis |
4.2% |
| Plantar Fasciitis |
4.2% |
|
| Secondary |
| Crohn's Disease |
36.6% |
| Product Used For Unknown Indication |
16.1% |
| Hypertension |
8.0% |
| Viral Hepatitis Carrier |
7.1% |
| Acute Lymphocytic Leukaemia |
3.6% |
| Colitis Ulcerative |
3.1% |
| Anxiety |
2.7% |
| Aspergillosis |
2.7% |
| Foreign Body In Eye |
2.7% |
| Lung Infection |
2.7% |
| Hepatitis C |
2.2% |
| Antidepressant Therapy |
1.8% |
| Chronic Graft Versus Host Disease In Skin |
1.8% |
| Graft Versus Host Disease |
1.8% |
| Antiviral Prophylaxis |
1.3% |
| Epilepsy |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Mineral Supplementation |
1.3% |
| Anaemia |
0.9% |
| Bone Marrow Conditioning Regimen |
0.9% |
|
| Weight Increased |
13.2% |
| Vomiting |
10.5% |
| Febrile Convulsion |
7.9% |
| Swelling Face |
7.9% |
| Diabetes Mellitus |
5.3% |
| Faeces Discoloured |
5.3% |
| Off Label Use |
5.3% |
| Panic Attack |
5.3% |
| Thrombocytopenia |
5.3% |
| Thrombotic Microangiopathy |
5.3% |
| Tuberculosis Gastrointestinal |
5.3% |
| Anxiety |
2.6% |
| Crohn's Disease |
2.6% |
| Haemoglobin Decreased |
2.6% |
| Immune System Disorder |
2.6% |
| Plantar Fasciitis |
2.6% |
| Pregnancy |
2.6% |
| Premature Labour |
2.6% |
| Pulmonary Tuberculosis |
2.6% |
| Rash Maculo-papular |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.2% |
| Crohn's Disease |
37.7% |
| Ankylosing Spondylitis |
2.3% |
| Pain |
2.2% |
| Depression |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Hypertension |
1.6% |
| Vitamin Supplementation |
1.4% |
| Anxiety |
1.3% |
| Colitis Ulcerative |
1.3% |
| Insomnia |
1.2% |
| Abdominal Pain |
1.2% |
| Premedication |
1.1% |
| Blood Pressure |
1.0% |
| Drug Use For Unknown Indication |
1.0% |
| Rheumatoid Arthritis |
1.0% |
| Nausea |
0.9% |
| Hypersensitivity |
0.7% |
| Prophylaxis |
0.7% |
| Supplementation Therapy |
0.7% |
|
| Vomiting |
16.5% |
| Injection Site Pain |
16.1% |
| Weight Decreased |
11.0% |
| Pyrexia |
5.5% |
| Pain |
5.0% |
| Weight Increased |
5.0% |
| Injection Site Bruising |
4.6% |
| Tumour Lysis Syndrome |
4.6% |
| Nausea |
4.1% |
| Urinary Tract Infection |
4.1% |
| Tonsillitis |
3.7% |
| Sinusitis |
2.8% |
| Fatigue |
2.3% |
| Injection Site Swelling |
2.3% |
| Sepsis |
2.3% |
| Vision Blurred |
2.3% |
| Wrong Technique In Drug Usage Process |
2.3% |
| Crohn's Disease |
1.8% |
| Fistula |
1.8% |
| Melaena |
1.8% |
|
